Emerald Health Therapeutics Pivots out of Recreational and Medical Cannabis and into Pharmaceutical Development Emerald Health Therapeutics plans to exit Canada’s recreational and medical cannabis sectors after racking up more than 200 million Canadian dollars ($156 million) in losses since its inception. “The Victoria, British Columbia-based business is the first mass-producer to choose to exit the cannabis industry..” The move comes after Emerald Health reported years of losses, underscoring how challenging the industry is to navigate for some executive teams. The company plans to sell off its recreational and medical cannabis assets and pivot to a focus on pharmaceutical development, where its board has more expertise, Emerald Health announced Monday. Emerald Health grew rapidly with Canada’s burgeoning cannabis industry but ultimately never made a profit in the sector. The company lost a total of CA$224.6 million between 2015 and June 2021. In that time, the company’s workforce grew from a couple of dozen employees to 166 in 2019, then fell to 111 this year. Emerald Health, which once was known by the corporate names T-Bird Pharma and Thunderbird Biomedical, owns various cannabis assets, including: 100% of the shares of EHTC, a British Columbia-based license holder. 100% of the shares of Verdélite Sciences, a Québec-based license holder. At one time, Emerald Health owned 41.3% of Pure Sunfarms, arguably Canada’s most successful mass-producer of cannabis. Solvent or Solventless? We can help. MJBizDaily Cannabis Extraction Buyers Guide Get strategies and tips from expert processors on choosing cannabis extraction systems, costs, safety precautions and more. Curated by MJBizDaily. Inside: How to choose between solvent-based and solventless extraction methods Learn which strains are most efficient for each extraction process Tips on safety precautions from design to training to protective equipment Get the Guide However, after relations soured between the two parties, Village Farms International bought out Emerald Health earlier this year for CA$79.9 million, which included CA$60 million in cash and the remainder due six months from the closing date. Emerald Health has had a turbulent year. The former CEO, Avtar Dhillon, was arrested in the United States on Aug. 3 and charged with conspiracy to commit securities fraud as well as two counts of obstruction of a proceeding before the U.S. Securities and Exchange Commission (SEC), according to a Glacier Media news report. Emerald said in a statement it became aware of Dhillon’s arrest on Aug. 5 but was “not aware of any improper trading in Emerald securities, and no allegations have been made against any other person associated with Emerald.” Dhillon resigned as Emerald chair on Aug. 6. Growing is all about the lighting: MJBizDaily Lighting Buyers Guide Read our exclusive guide for strategies and tips from expert cultivators who have amassed decades of experience studying horticulture lighting. Curated by MJBizDaily. Inside: Horticultural professionals debunk 8 common lighting myths in cannabis How cannabis extraction companies can reduce energy costs Why experts say the future of horticultural lighting is in LED technology Cannabis lighting Glossary of Terms Buyers checklist Get the Lighting Guide He had been a director of the company since April 23, 2015, and also helmed the industry body Cannabis Canada Council in 2018. The company’s CFO, Jenn Hepburn, stepped down in October. In November, Emerald signed an agreement to co-launch, sell and distribute cannabis beverages. It’s unclear where that partnership will go with Emerald’s planned exit from cannabis. Cannabis beverages have been a flop so far in Canada, with industrywide sales amounting to only CA$23.6 million, or just 1.3% of the Canadian cannabis market, in the first half of this year. In March, Emerald Health withdrew a registration statement relating to securities to raise up to CA$150 million. Earlier this year, Emerald Health delisted from the TSX Venture Exchange and listed its common shares on the Canadian Securities Exchange (CSE) in an attempt to try to capitalize on the American cannabis industry. No progress appears to have been made to that end. Emerald’s revenue in the latest quarter was CA$3.78 million with a net loss of CA$13.96 million. The company’s shares, which are traded as EMH on the CSE, are down 99% from their peak in early 2018.

Multiple Studies prove Marijuana and gaming, produce positive side effects to mental health, and going as far as pain relief Marijuana has had a bad reputation for a long time, from telling us it’s a gateway to other drugs to it hindering our cognitive function from long-term use. Still, there are scientific studies that show otherwise. How can being high help you? There have been many studies done on the topic of Marijuana and how it correlates to gaming, with positive side effects to mental health, and going as far as pain medication. Studies have shown that ingesting THC improves in-game performance by boosting focus and memory retention. This is surprising since marijuana is known for having negative effects on cognition and memory. However, many gamers have sworn that that cannabis is the only thing that helps them concentrate on gaming. This includes myself, for an avid smoker like me, getting high is as natural and drinking water, but when I am gaming it’s like a new person takes over. I have concentration beyond what I normally have, my reflexes are heightened to the point where I feel like someone else is playing through my body. Anxiety disorders are increasing at an alarming rate among people nowadays. A large workload, relationship issues, and tight timelines are all prevalent factors. All these factors work together to create sexual dysfunction, sleeplessness, and headaches. Cannabis has the capacity to cause endorphin release to help you feel more confident in yourself. You may progressively eliminate the issue of depression by using it on a daily basis. Research reveals the same thing, emphasizing cannabis’ capacity to boost cognitive capacities. As a result, cannabis serves as a therapeutic medication in the treatment of mental illness and aids in the cleaning of the mind to restore mental wellness. With this in mind, lets talk about the numerous positive effects on pain and the use of daily medication. Marijuana’s cannabinoids may alleviate pain by modifying pain perception circuits in the brain. This might be beneficial in the treatment of chronic pain disorder such as: Arthritis, Fibromyalgia, Endometriosis, and chronic migraines. It may also minimize cancer treatments side effects, like loss of appetite. In rare cases, medical marijuana has been observed to assist in the replacement on long-term usage of NASID’s like ibuprofen, which may have significant side effects. These are just the numerous ways that cannabis can have positive effect on the human body, for someone like me cannabis has become normal in everyday life, but I didn’t start out that way. My life has had a multitude of ups and downs; being kicked out of the house and health problems are a major factors of why cannabis has become part of my everyday life. There are so many more ways Marijuana can positively affect people with mental illness treatment to the affect it has on modern medicine.